Andrew Hirsch insider trades

Open-market stock purchases and sales by Andrew Hirsch, Director at Editas Medicine, Inc, from SEC Form 4 filings since Mar 11, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -54%.

Recent trades

DateStockTradeValue
Jun 17, 2026EDIT Editas Medicine, IncBought (not open market)—
Feb 15, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Feb 15, 2026CCCC C4 Therapeutics, IncSold (not open market)$17.1K
Feb 14, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Feb 14, 2026CCCC C4 Therapeutics, IncSold (not open market)$74K
Feb 13, 2026CCCC C4 Therapeutics, IncBought (not open market)—

Companies traded

  • EDIT Editas Medicine, Inc: other filings, last Jun 17, 2026
  • CCCC C4 Therapeutics, Inc: 1 buy, last Feb 15, 2026
  • AGIO Agios Pharmaceuticals, Inc: other filings, last Apr 22, 2020
  • BIND BIND Therapeutics, Inc: other filings, last Jun 22, 2015

Get free alerts when Andrew Hirsch files a new trade →